News

green ribbon

Board appointment to help drive growth at Neurovalens

Tina Lai Liedtky, president of the clinical diagnostics division at Massachusetts-headquartered scientific services giant Thermo Fisher Scientific, has been appointed to a non-executive position on Neurovalens' board of directors.

Based in Belfast and San Diego, Neurovalens creates non-invasive neurostimulation products used to solve some of the world's greatest health challenges, including diabetes, obesity, anxiety and insomnia. The vision of the company is to use technology that can influence the brainstem and hypothalamus in a non-invasive way to cure or treat neurological diseases without the need for implanted electrodes.